newsfilter
← Latest News
Business Wire·

PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights

Continued enrollment progress in Phase 3 REVERSE-IT clinical trial for Bentracimab Signed commercial supply agreement with BioVectra to support development and commercialization of lead product candidate bentracimab Completed underwritten public